FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968894854> ?p ?o ?g. }

• W2968894854 endingPage "1236" @default.
• W2968894854 startingPage "1228" @default.
• W2968894854 abstract "The balance between the host proinflammatory immune response and the counteracting anti-inflammatory and reparative responses supposedly determine the outcome of periapical lesions. In this scenario, the vasoactive intestinal peptide (VIP) may exert a protective role because of its prominent immunoregulatory capacity. In this study, we investigated (in a cause-and-effect manner) the potential involvement of VIP in the development of human and experimental periapical lesions.Periapical granulomas (n = 124) and control samples (n = 48) were comparatively assessed for VIP and multiple immunologic/activity marker expression through real-time polymerase chain reaction. Experimental periapical lesions (C57Bl/6 wild-type mice) were evaluated regarding endogenous VIP expression correlation with lesion development and the effect of recombinant VIP therapy in lesion outcome. CCR4KO and IL4KO strains and anti-glucocorticoid-induced TNFR-related protein inhibition were used to test the involvement of Treg and Th2 cells in VIP-mediated effects.VIP expression was more prevalent in periapical granulomas than in controls, presenting a positive association with immunoregulatory factors and an inverse association/correlation with proinflammatory mediators and the receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio. Endogenous VIP expression up-regulation was temporally associated with lesion immunoregulation and a decline of bone loss. VIP therapy in mice prompted the arrest of lesion development, being associated with an anti-inflammatory and proreparative response that limits the proinflammatory, Th1, Th17, and osteoclastogenic response in the periapex. The VIP protective effect was dependent of Treg migration and activity and independent of interleukin 4.Our results show that VIP overexpression in human and experimental periapical lesions is associated with lesion inactivity and that VIP therapy results in the attenuation of experimental lesion progression associated with the immunosuppressive response involving Treg cells." @default.
• W2968894854 created "2019-08-22" @default.
• W2968894854 creator A5020867458 @default.
• W2968894854 creator A5023657346 @default.
• W2968894854 creator A5029189140 @default.
• W2968894854 creator A5029216094 @default.
• W2968894854 creator A5054738435 @default.
• W2968894854 creator A5059668755 @default.
• W2968894854 creator A5061660387 @default.
• W2968894854 creator A5069899375 @default.
• W2968894854 creator A5069909687 @default.
• W2968894854 creator A5080376192 @default.
• W2968894854 creator A5081876904 @default.
• W2968894854 date "2019-10-01" @default.
• W2968894854 modified "2023-10-10" @default.
• W2968894854 title "Vasoactive Intestinal Peptide Immunoregulatory Role at the Periapex: Associative and Mechanistic Evidences from Human and Experimental Periapical Lesions" @default.
• W2968894854 cites W1557599311 @default.
• W2968894854 cites W1588310507 @default.
• W2968894854 cites W1970527859 @default.
• W2968894854 cites W1981939641 @default.
• W2968894854 cites W1988795715 @default.
• W2968894854 cites W1997412922 @default.
• W2968894854 cites W2004296512 @default.
• W2968894854 cites W2005353674 @default.
• W2968894854 cites W2007424370 @default.
• W2968894854 cites W2013102678 @default.
• W2968894854 cites W2020247976 @default.
• W2968894854 cites W2020536636 @default.
• W2968894854 cites W2032690551 @default.
• W2968894854 cites W2037522042 @default.
• W2968894854 cites W2047737819 @default.
• W2968894854 cites W2061651551 @default.
• W2968894854 cites W2062104384 @default.
• W2968894854 cites W2082323305 @default.
• W2968894854 cites W2089860109 @default.
• W2968894854 cites W2095058753 @default.
• W2968894854 cites W2097122459 @default.
• W2968894854 cites W2110179176 @default.
• W2968894854 cites W2117135396 @default.
• W2968894854 cites W2118854538 @default.
• W2968894854 cites W2120741277 @default.
• W2968894854 cites W2137181081 @default.
• W2968894854 cites W2211122879 @default.
• W2968894854 cites W2724814215 @default.
• W2968894854 cites W2794181759 @default.
• W2968894854 cites W2886551420 @default.
• W2968894854 cites W2896480807 @default.
• W2968894854 cites W2919971034 @default.
• W2968894854 doi "https://doi.org/10.1016/j.joen.2019.06.013" @default.
• W2968894854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31402064" @default.
• W2968894854 hasPublicationYear "2019" @default.
• W2968894854 type Work @default.
• W2968894854 sameAs 2968894854 @default.
• W2968894854 citedByCount "7" @default.
• W2968894854 countsByYear W29688948542019 @default.
• W2968894854 countsByYear W29688948542020 @default.
• W2968894854 countsByYear W29688948542021 @default.
• W2968894854 countsByYear W29688948542022 @default.
• W2968894854 crossrefType "journal-article" @default.
• W2968894854 hasAuthorship W2968894854A5020867458 @default.
• W2968894854 hasAuthorship W2968894854A5023657346 @default.
• W2968894854 hasAuthorship W2968894854A5029189140 @default.
• W2968894854 hasAuthorship W2968894854A5029216094 @default.
• W2968894854 hasAuthorship W2968894854A5054738435 @default.
• W2968894854 hasAuthorship W2968894854A5059668755 @default.
• W2968894854 hasAuthorship W2968894854A5061660387 @default.
• W2968894854 hasAuthorship W2968894854A5069899375 @default.
• W2968894854 hasAuthorship W2968894854A5069909687 @default.
• W2968894854 hasAuthorship W2968894854A5080376192 @default.
• W2968894854 hasAuthorship W2968894854A5081876904 @default.
• W2968894854 hasConcept C118303440 @default.
• W2968894854 hasConcept C126322002 @default.
• W2968894854 hasConcept C134018914 @default.
• W2968894854 hasConcept C142724271 @default.
• W2968894854 hasConcept C164027704 @default.
• W2968894854 hasConcept C16613235 @default.
• W2968894854 hasConcept C170493617 @default.
• W2968894854 hasConcept C203014093 @default.
• W2968894854 hasConcept C2776914184 @default.
• W2968894854 hasConcept C2781156865 @default.
• W2968894854 hasConcept C71924100 @default.
• W2968894854 hasConcept C8330315 @default.
• W2968894854 hasConcept C8891405 @default.
• W2968894854 hasConceptScore W2968894854C118303440 @default.
• W2968894854 hasConceptScore W2968894854C126322002 @default.
• W2968894854 hasConceptScore W2968894854C134018914 @default.
• W2968894854 hasConceptScore W2968894854C142724271 @default.
• W2968894854 hasConceptScore W2968894854C164027704 @default.
• W2968894854 hasConceptScore W2968894854C16613235 @default.
• W2968894854 hasConceptScore W2968894854C170493617 @default.
• W2968894854 hasConceptScore W2968894854C203014093 @default.
• W2968894854 hasConceptScore W2968894854C2776914184 @default.
• W2968894854 hasConceptScore W2968894854C2781156865 @default.
• W2968894854 hasConceptScore W2968894854C71924100 @default.
• W2968894854 hasConceptScore W2968894854C8330315 @default.
• W2968894854 hasConceptScore W2968894854C8891405 @default.
• W2968894854 hasFunder F4320320997 @default.
• W2968894854 hasFunder F4320321091 @default.

• next